Jump to main navigation Jump to main navigation Jump to main content Jump to footer content

Teamwork for a Complex Molecular Simulation

Technologie:Quantum Computing Forschungsbereich:Future Computing
11.11.2026

Quantum systems plus supercomputers plus artificial intelligence: for a simulation of how protein chains cleave, different computing technologies worked together. For this project universities, companies and the LRZ joined forces. The report about this scientific work has just been published, so it is time to ask an expert how hybrid computing works.

Autoproteolysis is a fascinating mystery of biology: some proteins are capable of activating themselves and cutting their peptide chain. A number of vital processes in the body, such as blood clotting and wound healing, are based on autoproteolysis. Faults in this process can contribute to diseases such as cancer or neurological disorders. So-called adhesion G-protein-coupled receptors (aGPCRs) play a central role in autoproteolysis; these are tiny mechanical switches on cell surfaces that are regarded as extremely promising targets for the development of new medicines.

Until now, supercomputers have only been able to model these dynamic processes in a rough manner. However, an interdisciplinary research group has now combined various computer technologies to carry out a large-scale molecular simulation. University College London (UCL), Ludwig-Maximilians-University (LMU) and the Technical University (TUM) of Munich, in collaboration with the Leibniz Supercomputing Centre (LRZ) and the technology providers IQM Quantum Computers, QMatter and NVIDIA joined forces to develop the mathematical and technical methods required to simulate protein cleavage processes in significantly greater detail through a hybrid combination of quantum and supercomputing, as well as artificial intelligence (AI).

The group had already published its work and research findings in spring; it has now followed this up with a detailed paper entitled “Multiscale Quantum-Classical Simulation of Protein Autoproteolysis in a Million-Atom Membrane Environment”. Computer scientist Dr Minh Chung supported the project at the LRZ – and describes in the paper and in an interview how hybrid computing using different technologies works.

Universities, companies and the LRZ were involved in the simulation – why, and how were the tasks allocated?
Dr Minh Chung:
The use case is a classic quantum chemistry or molecular simulation; in other words, it is not, at first glance, a new computational method, but one that has been difficult to carry out so far, even with supercomputers. Molecules consist of two or more atoms, which in turn contain electrons. To visualise processes within a molecule, one has to try out every possible arrangement of electrons and atoms – millions upon millions of possible variations. In 2023, the Quantum-Selected Configuration Interaction (QSIC) was introduced as a solution to such problems and is one part of our use case. In very simple terms, the quantum computer identifies the most important arrangements, which are then calculated by classical computers. In our project, the UCL team led by Prof. Peter Coveney discovered that protein cleavage involving the aGPCRs takes place in particularly active regions of the molecule, which could also be modelled on the quantum computer. Using QMatter, the UCL team developed a model of a molecule comprising a receptor, peptide chains and active regions, consisting of more than 1.17 million atoms, along with the corresponding calculation formulas and algorithms for supercomputers and quantum computers. LMU, TUM and IQM were responsible for the technical aspects, namely the calibration and error correction of Euro-Q-Exa, as well as the integration of experimental data, images and software into the qubits and onto the HPC and AI systems. Finally, we measured the results of the quantum system. NVIDIA provided support for software development based on the CUDA-Q programming framework and for the access to GPUs.

Picture credit: © LRZ | V.Hohenegger; adobe.stock.com – RareStock

Which LRZ systems were deployed?
Chung:
We launched the project about a year ago and have carried out test calculations on various systems to scale them up to increasingly larger molecules. We therefore started by using 20, then finally 52 qubits from Euro-Q-Exa. We also carried out calculations using HPC resources from the BEAST test environment, which includes GPUs and direct connection to the Euro-Q-Exa system of this use case. In the pipeline of this use case, there are compute-intensive steps as post-processing that requires GPUs for acceleration. We increased the number of GPUs with the BDAI systems and finally with NVIDIA’s, in total up to 1,200. Our aim was to find out whether scaling up the systems has any benefits to the calculations or not.

However, quantum computers, HPC systems and AI systems are based on different mathematical methods.
Chung:
How the simulation tasks are distributed between different architectures depends entirely on the computational complexity of each molecular sub-problem. We first get a clear picture of the required tasks, develop a pipeline for pre- and post-processing the data, and then decide which combination of algorithm and architecture is best suited to carry out which tasks. For the classical components of a molecular simulation like this, we rely on established, validated open-source software and structural models, which are standard in the science community. For hybrid computing, it is essential that this same level of abstraction and rigorous validation is maintained when transitioning to quantum architectures. While several frameworks and libraries are currently emerging to support this integration and preserve software maturity, our project specifically leveraged CUDA-Q to achieve this unified, validated environment for all technologies.

Do the results from the various systems differ? How? 
Chung:
A quantum computer does not produce a single result like a classical computer, but rather a probability distribution across possible outcomes. Ultimately, however, we always end up with digital calculation results that we can work with. More important than the results is the question of which system is best suited for which part of the calculation. Supercomputers deliver the best results for computationally intensive tasks; they process large amounts of data and carry out extensive calculations, often in numerous iterations thanks to their parallelised architecture. Quantum computers are currently still limited by the number of available qubits, so they cannot yet handle very large calculations on their own. The challenge, therefore, lies in identifying the particularly complex and difficult parts of a calculation that are suitable for quantum computing.

At the moment, one more Euro-Q-Exa system with the computing power of 150 qubits is being installed at LRZ. Could the molecular simulation then be carried out entirely on a quantum computer, and would that make sense?
Chung:
In principle, that could be possible, but it would require a fundamental redesign of the entire pipeline to run natively on a quantum computer. Given the current constraints around qubit counts and error rates, relying solely on quantum hardware isn't realistic yet. That’s why a hybrid approach - integrating HPC, AI, and quantum computing - is so compelling, and it’s precisely what our project delivers. Our project is specifically designed around the collaboration of multiple technologies. Running the simulation solely on a supercomputer would probably not yield results of the same quality. Whether it makes sense to perform the molecular simulation on a larger system such as the bigger Euro-Q-Exa computer is ultimately a question for chemists and biologists. I can imagine that a larger system could enable even more detailed modelling of the active regions of aGPCRs and a deeper understanding of their mechanisms and functions. (LRZ | vs)

Translation generated using AI 

 

We want to provide you with the most important information and services in the best possible way. In order to do this, we need your consent to use the web analysis tool »Matomo« to create and evaluate an anonymous analysis of your visit for statistical purposes. You can change your consent at any time on the data protection page, otherwise it will remain valid for twelve months.